LongevityEvidence: Emerging6 min read

NAD+: Where the Science Is Solid and Where the Delivery Argument Falls Apart

NAD+ is not a peptide, but it sits in nearly every peptide catalogue we index — so it belongs in this library. The biology is well established; the product claims often are not.

500mg

Typical vial

$49

Lowest tracked

$78

Median price

121

Vendors listing

The underlying biology is not in dispute

NAD+ is a coenzyme central to redox reactions and to sirtuin and PARP activity. Around 210 studies in our index touch it. What is contested is whether administering NAD+ directly is the best way to raise cellular levels.

The precursor argument

Much of the human research investment has gone into precursors such as NR and NMN rather than NAD+ itself, on the basis that the intact molecule is poorly taken up by cells.

Vendors rarely acknowledge this debate. We grade the evidence Emerging for that reason: strong background science, unsettled delivery question.

Stability and handling

NAD+ degrades faster than most compounds in this index, particularly in solution and at room temperature. Cold-chain claims and reconstitution guidance are more meaningful signals here than elsewhere.

Pricing

500mg vials typically run £39 to £62. Per-milligram cost is low, but shipping and storage requirements affect real cost more than the sticker price does.

Frequently asked

Is NAD+ a peptide?

No, it is a coenzyme. It is included here because it appears throughout the same supplier catalogues.

NAD+ or a precursor?

The research community has not settled this. Treat confident vendor claims either way with caution.

Search focus for this profile

nad+ injection3,600/mo searches, difficulty 22/100 — easy. Source: Semrush (UK database).

Supporting terms covered: nad+ review, nad+ vs nmn, nad+ stability testing.

Everything below describes published research and market data. Nothing here is medical advice, and none of these compounds are sold or supplied by CheckALab.

More in Longevity